Skip to main content

Table 1 B-Raf inhibitors in phase I/II clinical trials

From: B-Raf and the inhibitors: from bench to bedside

Drugs

Disease

Clinical trial ID*

LGX818

Advanced melanoma

NCT01436656

Dabrafenib (GSK2118436)

Solid tumors

NCT00880321

XL281

Solid tumors

NCT00451880

ARQ-736

Advanced solid tumors

NCT01225536

RO5212054 (PLX3603)

Advanced solid tumors

NCT01143753

RAF265

Advanced melanoma

NCT00304525

  1. *details available at http://www.clinicaltrials.gov.
Back to article page

Journal of Hematology & Oncology

ISSN: 1756-8722

Contact us